Introduction
============

Brucellosis is a major zoonotic problem worldwide and an economically important disease associated with severe illness in humans and abortion and sterility in many domestic and wild animals \[[@B6][@B15][@B17]\]. The disease is caused by *Brucella* (*B*.) species, a small, non-motile, aerobic, Gram-negative coccobacillus that is highly contagious to humans and possesses the ability to invade and proliferate within host cells and evade the immune system, leading to chronic disease \[[@B12][@B17]\]. The disease is also considered an occupational hazard to slaughterhouse workers, butchers and veterinarians because it can be transmitted via direct animal contact, inhalation, or the consumption of unpasteurized milk or other dairy products and undercooked meat products. The pathological manifestations include arthritis, endocarditis and meningitis \[[@B6][@B14]\].

The transmission of brucellosis varies with geographical conditions, climate, age, gender and species, but it is usually transmitted by sexually mature animals. After invading the lymphoid system, the pathogen proliferates within mononuclear phagocytes and disseminates in specific locations of the body, including the spleen, brain, heart and bones \[[@B2]\]. The development of an effective medical therapy for the disease is difficult because of its intracellular replication properties, which result in chronic infection and problems with multiple antibiotic regimens \[[@B11]\]. There are several obstacles to use of combinations of antibiotics for the treatment of this disease, including financial issues, therapeutic failures, and health and safety concerns. Therefore, the use of a safe alternative treatment, particularly natural plant products that can eliminate the various complications associated with brucellosis, must be explored.

Korean ginseng (the root of *Panax ginseng* Meyer) is a valuable medicinal herbs widely used as a supplementary herbal medicine for the treatment of cancer, diabetes and atherosclerosis \[[@B3][@B5]\]. The major active compounds of ginseng are ginsenosides, which have antidiabetic, anticancer and anti-inflammatory effects \[[@B3]\]. Other active constituents include acidic polysaccharides, which have been shown to possess either immunostimulatory or immunosuppressive effects depending on the length of treatment and disease environments \[[@B18]\]. Acidic polysaccharides are known to promote the production of cytotoxic cells against tumors, stimulate macrophages to produce T helper types 1 and 2 (Th1 and Th2), modulate antioxidant defense systems and suppress acute inflammatory responses at an early phase of *Staphylococcus aureus* infection \[[@B18]\]. However, the effects of acidic polysaccharides on the control of *Brucella* have not been explored.

In the present study, we investigated the effects of red ginseng acidic polysaccharide (RGAP) on invasion and intracellular survival inhibition in macrophages during *B. abortus* infection. The inhibitory effects suggest that this plant could be a promising alternative for the control and/or treatment of brucellosis.

Materials and Methods
=====================

RGAP preparation
----------------

Red ginseng acidic polysaccharide (RGAP) was isolated as previously described by the Institute of Technology, Korea Ginseng Corporation, Daejeon, Korea \[[@B10]\]. RGAP was stored as a dried powder at 4℃ until use. For the experiments, it was dissolved in sterile phosphate-buffered saline solution (PBS; pH 7.4) and filtered through 0.45 µm membranes (Minisart; Sartorius Stedim Biotech, Germany).

Cell culture
------------

Murine macrophage RAW 264.7 cells (ATCC; TIB-71) were grown and prepared as previously described \[[@B11]\]. For all assays, macrophages were seeded on culture plates at a concentration of 1 × 10^5^ cells per well and incubated overnight prior to infection.

Bacterial culture
-----------------

The standard wild-type strains were derived from *B. abortus* 544 (ATCC 23448), a smooth, virulent *B. abortus* biovar 1 strain. The organism was cultivated in Brucella broth (Becton, Dickinson and Company, USA) or Brucella broth containing 1.5% agar (Becton, Dickinson and Company) at 37℃.

Bactericidal assay
------------------

Bacteria (2 × 10^4^ colony-forming units \[CFU\]/mL) were added to different concentrations of RGAP (0, 0.01, 0.1, 1, 2 and 4 mg/mL) and incubated at 37℃ for 0, 2, 4, 8 and 24 h. After incubation and dilution, 50 µL of each diluent was plated on *Brucella* agar and incubated at 37℃ for 3 days, after which bacterial survival rates were expressed as previously described \[[@B11]\].

Cytotoxicity assay
------------------

RAW 264.7 cells were cultured in the presence of different concentrations of RGAP (0, 0.01, 0.1, 1, 1.5, 2, 4 mg/mL) in a 96-well cell culture plate for 48 h. Following incubation with RGAP, cytotoxicity was analyzed using a colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test as previously described \[[@B11]\].

Invasion and intracellular growth of *B. abortus*
-------------------------------------------------

RAW 264.7 cells were pretreated with the highest non-cytotoxic concentration of RGAP (0.1 mg/mL) or PBS (negative control) for 4 h prior to infection for analysis of the bacterial internalization efficiency. The bacteria were then deposited onto cells at multiplicities of infection (MOIs) of 100, centrifuged at 150 × g for 10 min at room temperature and incubated at 37℃ in 5% CO~2~ for 0 and 30 min. The infected cells were washed with PBS and then incubated at 37℃ in fresh medium containing fetal bovine serum (FBS) and gentamicin (30 µg/mL) for 30 min. Next, cells were washed using PBS and lysed with distilled water. Bacterial CFUs were measured by serial dilutions on *Brucella* agar plates. To measure the intracellular growth efficiency, bacterial infection was induced as described for bacterial internalization, after which infected cells were incubated at 37℃ for 1 h, washed with PBS, incubated on RPMI 1640 containing 10% (v/v) FBS and gentamicin (30 µg/mL) with RGAP (0.1 mg/mL) or PBS and then incubated for 2, 24 or 48 h. Finally, cells were washed and lysed as for the analysis of bacterial internalization efficiency.

Bacterial adherence assay
-------------------------

RAW 264.7 cells were cultured in 12-well plates with 18 mm diameter glass coverslips (Fisher Scientific, Pittsburgh, PA). The cells were pre-incubated with RGAP (0.1 mg/mL) for 4 h, with cytochalasin D (0.5 mg/mL) added during the last 40 min of pre-incubation to inhibit bacterial internalization. The samples were then infected with *B. abortus* and centrifuged at 150 × g for 10 min at RT, after which they were incubated at 37℃ in 5% CO~2~ for 30 min. The cells were subsequently washed three times with PBS, fixed with 4% paraformaldehyde and incubated at 37℃ for 30 min. The adherent bacteria on the cell surface within 30 min of infection were monitored, after which the cells were washed three times with PBS and then permeabilized at −20℃ in methanol for 10 sec. The adherent bacteria were then stained with anti-*B. abortus* polyclonal rabbit serum (1 : 500) and fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit immunoglobulin G (IgG) (1 : 500). The staining procedures were performed for 1 h at 37℃. Fluorescence images were collected using a microscope (Olympus IX70; Olympus, Japan) equipped with a digital camera (Nikon D5100; Nikon, Thailand) and analyzed as previously described \[[@B11]\].

F-actin and lysosome-associated membrane protein 1 (LAMP-1) staining by immunofluorescence microscopy
-----------------------------------------------------------------------------------------------------

RAW 264.7 macrophages were cultured and pretreated with RGAP as described for the bacterial adherence assay. The cells were then infected with FITC (Sigma-Aldrich, USA)-conjugated or unconjugated *B. abortus*. To observe F-actin reorganization, bacterial infection was monitored for 10 min as previously described \[[@B11]\]. Briefly, to detect co-localization of *B. abortus*-containing phagosomes (BCPs) with LAMP-1, bacterial infection with unconjugated *B. abortus* was performed for 1 h, after which cells were washed with medium and then incubated with fresh medium containing FBS, gentamicin and RGAP for 2 h. The infected cells were subsequently fixed, permeabilized with 0.1% Triton X-100 for 10 min at 22℃, and incubated with blocking buffer (2% goat serum in PBS) for 30 min. For F-actin staining, the cells were incubated with 0.1 µM rhodamine-phalloidin (Cytoskeleton, USA) for 30 min at 22℃. For LAMP-1 staining, all staining procedures were performed for 1 h at 37℃ using anti-LAMP-1 rat monoclonal antibody (1 : 100), Texas red-goat anti-rat IgG (1 : 1,000), anti-*B. abortus* rabbit serum (1 : 500) and FITC-conjugated goat serum (1 : 500). Blocking was performed using 2% goat serum in PBS for 30 min at 37℃. After final washing, the samples were mounted with DakoCytomation fluorescent mounting medium (Dako, USA) on microscope slides (Paul Marienfeld, Germany) and fluorescence images were collected using a laser scanning confocal microscope (FV1000; Olympus). Finally, data were processed using the FV10-ASW Viewer 3.1 software and analyzed as previously described \[[@B11]\].

F-actin analysis
----------------

RAW 264.7 cells were cultured in 6-well plates and pretreated with RGAP as described in the bacterial adherence assay. The cells were infected for 30 min, fixed, permeabilized and stained as previously described \[[@B11]\]. The F-actin content was quantified using a FACSCalibur flow cytometer (BD Biosciences, USA). All experiments were performed in duplicate and repeated at least three times.

Immunoblot analysis
-------------------

Immunoblot analysis was conducted as described by MacPhee \[[@B13]\]. Briefly, RAW 264.7 cells were cultured in 6-well plates, treated with 0.1 mg/mL RGAP and infected with *B. abortus* for the indicated times. The cells were then washed twice with ice-cold PBS and lysed using ice-cold radioimmunoprecipitation assay (RIPA) buffer with 1% protease inhibitor cocktail for 30 min at 4℃. The protein concentration was then measured using a Bradford protein assay (Bio-Rad Laboratories, USA). Next, samples were separated by SDS-PAGE and transferred onto an Immobilon-P membrane (Millipore, USA) using 1× transfer buffer (25 mM Tris, 192 mM glycine and 20% methanol) as previously described \[[@B11]\]. The immunoblot signals were quantified using the ImageJ software (National Institutes of Health, USA).

Statistical analysis
--------------------

The data are expressed as the means ± standard deviation (SD) for replicate experiments. Statistical analysis was conducted using the GraphPad Prism software (ver 4.00; GraphPad Software, USA). A Student\'s *t*-test or one-way ANOVA was used for statistical comparisons between groups. A *p* \< 0.05 was considered statistically significant.

Results
=======

Effect of RGAP on *B. abortus* survival rates and murine macrophage viability
-----------------------------------------------------------------------------

The bacterial survival rates did not differ upon incubation with various concentrations of RGAP (0.01, 0.1, 1, 2 and 4 mg/mL), indicating that RGAP had no bactericidal effect against *B. abortus* at any of the concentrations used in the experiment. When RAW 264.7 cells were incubated for 48 h with various concentrations of RGAP (0, 0.01, 0.1, 1, 1.5, 2, 4 mg/mL), the OD values of the cells cultured at concentrations from 1 to 4 mg/mL RGAP decreased markedly. However, the OD values observed in the presence of RGAP at 0.1 mg/mL did not decrease significantly compared with the OD values of untreated control cells. These results indicate that RGAP did not have any cytotoxic effects on RAW 264.7 cells at ≤ 0.1 mg/mL. Therefore, the highest non-cytotoxic concentration of RGAP (0.1 mg/mL) was used for the subsequent experiments.

Effect of RGAP on *B. abortus* invasion and intracellular growth in murine macrophages
--------------------------------------------------------------------------------------

The invasion of *B. abortus* in RAW 264.7 cells was verified by pre-incubation with the highest non-cytotoxic concentration of RGAP (0.1 mg/mL) for the indicated times (0, 30 min). The results indicate that the invasion of *B. abortus* into RGAP-treated cells was significantly reduced compared with the untreated control (*p* \< 0.05) (panel A in [Fig. 1](#F1){ref-type="fig"}). Furthermore, RGAP-treated cells displayed significantly reduced intracellular growth of *B. abortus* at 2, 24 and 48 h post-infection compared with the untreated control cells (panel B in [Fig. 1](#F1){ref-type="fig"}).

Effect of RGAP on *B. abortus* phagocytosis
-------------------------------------------

The adherence of *B. abortus* on RAW 264.7 cells was significantly reduced by pre-incubation with RGAP (28 ± 2) relative to untreated control cells (53 ± 2.65), showing a reduction rate of 47.17 ± 1.08% (*p* \< 0.001) ([Fig. 2](#F2){ref-type="fig"}).

Phalloidin-associated F-actin fluorescence microscopy indicated diminished F-actin polymerization for *B. abortus* invasion in RGAP-treated cells compared with untreated control cells and showed a reduction in filopodia and lamellipodia scattering in the peripheral cells (panel A in [Fig. 3](#F3){ref-type="fig"}). Because F-actin polymerization is required for *B. abortus* phagocytosis, the F-actin content of RGAP-treated cells upon *B. abortus* invasion was assessed and quantified. Fluorescence-activated cell sorting (FACS) analysis revealed that treatment of murine macrophages with RGAP significantly reduced the F-actin content in these cells upon bacterial infection, as indicated by decreased F-actin fluorescence intensity compared with *B. abortus*-infected untreated cells (panel B and C in [Fig. 3](#F3){ref-type="fig"}). The F-actin content of the uninfected RGAP-treated cells showed no significant difference from the untreated control cells.

The phosphorylation levels of ERK1/2, JNK and p38α in RGAP-treated cells at 30 min post-infection were reduced by 27.58%, 34.76% and 47.92%, respectively, compared with *B. abortus*-infected control cells ([Fig. 4](#F4){ref-type="fig"}). These findings indicate that RGAP suppressed the activation of MAPKs in RAW 264.7 cells, which inhibited the invasion of *B. abortus* into macrophages. In addition, co-localization of LAMP-1 with BCPs in RGAP-treated cells was observed to markedly increase, showing a significant increase of up to 2.03-fold after 2 h of incubation relative to untreated control cells (*p* \< 0.001) ([Fig. 5](#F5){ref-type="fig"}).

Discussion
==========

*Brucella spp*. are highly infectious to humans, with an annual incidence of approximately 500,000 cases worldwide \[[@B6][@B17]\]. Furthermore, there is no safe, licensed and effective vaccine currently available to control human brucellosis. Consequently, the application of traditional medicine and natural products to control brucellosis should be explored.

Korean ginseng (the root of *Panax ginseng* Meyer), which is one of the most valuable medicinal herbs, is mainly used to maintain homeostasis in the body. Some of its identified pharmacological efficacy involves improved brain function, pain-relieving effects, antitumor activity, anti-stress effects and anti-aging effects \[[@B5]\]. One of its reported active ingredients is acidic polysaccharide, which has been shown to have immunostimulatory functions including up-regulation of the functional roles of natural killer cells and macrophages linked to antitumor activities in several studies \[[@B3]\]. Although ginseng has been shown to improve microbial clearance from the body and studies have shown that acidic polysaccharide can be used as a remedy for influenza viral infection, its potential therapeutic efficacy against *Brucella* has not been clinically examined \[[@B8][@B18]\].

Microbial adhesion to host cells is essential to successful establishment of infection, and is crucially dependent on specific cell-to-bacterial interactions mediated by specific cell surface adhesion molecules. Studies have shown that ginseng polysaccharides can interrupt microbial adhesion to host cells, thereby preventing the establishment of infectious diseases including *Porphyromonas gingivalis*, *Actinobacillus actinomycetemcomitans*, *Propionibacterium acnes* and *Staphylococcus aureus* \[[@B8]\]. In the present study, we examined the effect of RGAP on *B. abortus* adhesion to phagocytic cells. In agreement with previous studies, our results showed that RGAP interferes with the adherence of *B. abortus* to the macrophage cell membrane *in vitro*, suggesting that it could inhibit the adherence of *B. abortus* to macrophage surface membranes during infection. Consistent with the interfering effect of RGAP on the adherence of *B. abortus* to macrophages, the invasion of this pathogen in RGAP-treated cells also decreased significantly when compared to the untreated control. These findings indicate that RGAP has an inhibitory effect on *B. abortus* phagocytosis by inhibiting F-actin polymerization, which is required for the uptake of these microorganisms into the host cell.

A significant reduction in the number of *Staphylococcus aureus* recovered in the spleen, kidneys and blood of mice and protection from lethal sepsis upon treatment with acidic polysaccharide was observed \[[@B1]\]. The bacterial load and lung pathology caused by *Pseudomonas aeruginosa* in rats that were treated with an aqueous extract of ginseng were also reduced \[[@B16]\]. Therefore, RGAP could account for the inhibitory effects of Korean red ginseng against *Brucella* infection. Mitogen-activated protein kinase (MAPK) has also been shown to play an important role in bacterial phagocytosis and actin cytoskeleton remodeling \[[@B9]\]. The treatment of peritoneal macrophages with acidic polysaccharides after subsequent exposure to heat-killed *S. aureus* reduced the expression of phospho-JNK1/2 and p38 MAPK \[[@B1]\]. In the present study, we investigated the phosphorylation of MAPKs in macrophages in the presence or absence of RGAP during *B. abortus* invasion. In agreement with the previous study, our findings revealed that RGAP reduced the expression of MAPKs (ERK1/2, JNK and p38α) in *B. abortus*-infected macrophages. Consequently, these findings indicate that the inhibitory effects of RGAP on MAPKs-linked phagocytic signaling pathways could disrupt F-actin polymerization and subsequent *B. abortus* invasion in macrophages.

In our study, the incubation of macrophages with RGAP after *B. abortus* infection significantly reduced intracellular survival of *B. abortus*. One of the strategies for the intracellular survival of virulent *B. abortus* is its ability to progressively inhibit phagosome-lysosome fusion followed by maturation of *Brucella*-containing phagosomes (BCPs) into replicative phagosomes or brucellosomes \[[@B4]\]. Therefore, we investigated the involvement of RGAP in *B. abortus* intracellular trafficking in macrophages by demonstrating its effect on the interaction of BCPs with LAMP-1. LAMPs are transmembrane proteins with a large, heavily glycosylated luminal domain and a short cytosolic tail required for fusion of lysosomes with phagosomes, which form organelles with degradative and antimicrobial components essential for the killing of internalized microorganisms \[[@B7]\]. In this study, LAMP-1 staining revealed enhanced phagosome-lysosome fusion of *B. abortus* for up to 48 h, which suggests that RGAP inhibits bacterial intracellular replication by enhancing early and late phagosome-lysosome fusion of *Brucella* within macrophages.

In conclusion, our results suggest that RGAP modulates *B. abortus* pathogenesis by inhibiting phagocytosis and intracellular replication in macrophages. These findings will facilitate development of a safe and economical alternative approach to the prevention and/or control of brucellosis in livestock industries and humans that can be applied as a component in feed additives or in natural food products and medicines.
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![Effect of red ginseng acidic polysaccharide (RGAP) on invasion and intracellular growth of *Brucella* (*B*.) *abortus*. (A) Bacterial internalization efficiency. (B) Bacterial intracellular growth efficiency. Data represent the means ± SD of duplicate samples in at least three independent experiments. Statistically significant differences relative to the untreated control are indicated by asterisks (^\*^*p* \< 0.05; ^\*\*^*p* \< 0.01; ^\*\*\*^*p* \< 0.001).](jvs-17-315-g001){#F1}

![Effect of RGAP on the adherence of *B. abortus* to macrophages. Fluorescence images were collected using a microscope equipped with a camera. One hundred macrophages were selected at random, and the bacteria that adhered to the cells were counted. Data represent the mean ± SD of triplicate samples in at least three independent experiments. Statistically significant differences relative to the untreated control are indicated by asterisks (^\*\*\*^*p* \< 0.001).](jvs-17-315-g002){#F2}

![Fluorescence-activated cell sorting (FACS) analysis of the effects of RGAP on phagocytosis of *B. abortus* by F-actin polymerization modulation. (A) F-actin polymerization and bacterial co-localization (scale bars = 5 µm). (B) FACS analysis for F-actin content. (C) Intensification of F-actin polymerization. The data shown are representative of at least three independent experiments. Statistically significant differences relative to untreated control cells are indicated by an asterisk (^\*^*p* \< 0.05). DIC, differential interference contrast.](jvs-17-315-g003){#F3}

![Effect of RGAP on activation of intracellular signaling for the phagocytosis of *B. abortus*. Immunoblot analyses of total RAW 264.7 cell lysates pre-treated with RGAP were assessed using phospho-specific ERK1/2, JNK and p38α antibodies at the indicated times. Images shown are representative of at least three independent experiments.](jvs-17-315-g004){#F4}

![Effect of RGAP on intracellular trafficking of *B. abortus*. One hundred bacteria within macrophages were randomly selected, and the extent of LAMP-1 acquisition by the bacteria was determined. Data represent the means ± SD of triplicate samples. Statistically significant differences relative to the untreated control are indicated by asterisks (^\*\*\*^*p* \< 0.001).](jvs-17-315-g005){#F5}
